Literature DB >> 19701252

Multivariate analyses of immune reconstitution in children after allo-SCT: risk-estimation based on age-matched leukocyte sub-populations.

M Koenig1, S Huenecke, E Salzmann-Manrique, R Esser, R Quaritsch, D Steinhilber, H H Radeke, H Martin, P Bader, T Klingebiel, D Schwabe, G Schneider, T Lehrnbecher, A Orth, U Koehl.   

Abstract

The speed of immune recovery after allo-SCT is of central importance to overcome infectious complications and relapse. To evaluate the immune reconstitution of pediatric patients concerning overall survival, we developed a three-component multivariate model and generated a reference domain of ellipsoidal shape on the basis of normal leukocyte subtype values of 100 healthy children and adolescents. The leukocyte subtypes include absolute nos. of leukocytes, CD14(+) monocytes, lymphocytes, CD3(+) T cells, CD3(+)CD4(+) helper T cells, CD3(+)CD8(+) cytotoxic T cells, CD3(-)CD56(+) natural killer-cells and CD19(+) B cells, all of which are correlated, thus, requiring the application of multivariate as opposed to multiple univariate modeling. According to their immune reconstitution, 32 pediatric patients post allo-SCT were classified into low-risk and high-risk groups on the basis of our new model. Therefore, we evaluated if the patients reached the ellipsoid of normal leukocyte sub-population values post SCT. We detected a significantly higher number of long-time survivors among the low-risk group compared with the high-risk group at days 200 (P=0.001) and 300 (P<0.0001). This is superior to our previously published univariate analysis. Combined with the clinical observation, a classification into risk groups based on an extended patient cohort may represent a predictor for complications.

Entities:  

Mesh:

Year:  2009        PMID: 19701252     DOI: 10.1038/bmt.2009.204

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  11 in total

1.  Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation.

Authors:  M C Elze; O Ciocarlie; A Heinze; S Kloess; T Gardlowski; R Esser; T Klingebiel; P Bader; S Huenecke; M Serban; U Köhl; J L Hutton
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

2.  Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.

Authors:  Sylvia Borchers; Melanie Bremm; Thomas Lehrnbecher; Elke Dammann; Brigitte Pabst; Benno Wölk; Ruth Esser; Meral Yildiz; Matthias Eder; Michael Stadler; Peter Bader; Hans Martin; Andrea Jarisch; Gisbert Schneider; Thomas Klingebiel; Arnold Ganser; Eva M Weissinger; Ulrike Koehl
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

Review 3.  Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology.

Authors:  Charlotte I S Barker; Eva Germovsek; Rollo L Hoare; Jodi M Lestner; Joanna Lewis; Joseph F Standing
Journal:  Adv Drug Deliv Rev       Date:  2014-01-17       Impact factor: 15.470

4.  Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections.

Authors:  Sabine Huenecke; Claudia Cappel; Ruth Esser; Verena Pfirrmann; Emilia Salzmann-Manrique; Sibille Betz; Eileen Keitl; Julia Banisharif-Dehkordi; Shahrzad Bakhtiar; Christoph Königs; Andrea Jarisch; Jan Soerensen; Evelyn Ullrich; Thomas Klingebiel; Peter Bader; Melanie Bremm
Journal:  Front Immunol       Date:  2017-02-10       Impact factor: 7.561

5.  Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34+-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study.

Authors:  Emilia Salzmann-Manrique; Melanie Bremm; Sabine Huenecke; Milena Stech; Andreas Orth; Matthias Eyrich; Ansgar Schulz; Ruth Esser; Thomas Klingebiel; Peter Bader; Eva Herrmann; Ulrike Koehl
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

6.  Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience.

Authors:  Michael Merker; Michael Torsten Meister; Annekathrin Heinze; Andrea Jarisch; Jan Sörensen; Sabine Huenecke; Melanie Bremm; Claudia Cappel; Thomas Klingebiel; Peter Bader; Eva Rettinger
Journal:  Oncotarget       Date:  2019-10-22

Review 7.  Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions.

Authors:  Asaf Yanir; Ansgar Schulz; Anita Lawitschka; Stefan Nierkens; Matthias Eyrich
Journal:  Front Pediatr       Date:  2022-01-11       Impact factor: 3.418

8.  Multivariate Analysis of Immune Reconstitution and Relapse Risk Scoring in Children Receiving Allogeneic Stem Cell Transplantation for Acute Leukemias.

Authors:  Manuela Spadea; Francesco Saglio; Serena I Tripodi; Mariacristina Menconi; Marco Zecca; Franca Fagioli
Journal:  Transplant Direct       Date:  2021-10-06

9.  Bayesian Modeling Immune Reconstitution Apply to CD34+ Selected Stem Cell Transplantation for Severe Combined Immunodeficiency.

Authors:  Jean-Sebastien Diana; Naïm Bouazza; Chloe Couzin; Martin Castelle; Alessandra Magnani; Elisa Magrin; Jeremie Rosain; Jean-Marc Treluyer; Capucine Picard; Despina Moshous; Stéphane Blanche; Bénédicte Neven; Marina Cavazzana
Journal:  Front Pediatr       Date:  2022-02-15       Impact factor: 3.418

10.  Flow Cytometric Analyses of Lymphocyte Markers in Immune Oncology: A Comprehensive Guidance for Validation Practice According to Laws and Standards.

Authors:  Claude Lambert; Gulderen Yanikkaya Demirel; Thomas Keller; Frank Preijers; Katherina Psarra; Matthias Schiemann; Mustafa Özçürümez; Ulrich Sack
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.